Celularity Inc.CELUNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank71
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-156.64%
↑ 69% vs avg
Percentile
P71
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-497.95%
Historical baseline
PeriodValueYoY Change
TTM-156.64%-94.3%
2024-80.61%+90.0%
2023-807.81%-4.6%
2022-772.36%-87.0%
2021-412.98%+70.9%
2020-1417.60%-322.4%
2019-335.63%-5365729.0%
2018-0.01%-